Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer
- 1 April 2001
- Vol. 57 (4) , 77-80
- https://doi.org/10.1016/s0090-4295(00)00946-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evidence for the differential expression of a variant EGF receptor protein in human prostate cancerBritish Journal of Cancer, 2000
- New insights into the regulation of protein kinase C and novel phorbol ester receptorsThe FASEB Journal, 1999
- Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesisOncogene, 1998
- Growth factor network disruption in prostate cancer progression.Cancer and Metastasis Reviews, 1998
- The TAO of MEKKFrontiers in Bioscience-Landmark, 1998
- Genistein-Induced Apoptosis of Prostate Cancer Cells is Preceded by a Specific Decrease in Focal Adhesion Kinase ActivityMolecular Pharmacology, 1997
- Comparative analysis of mrna and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissueHuman Pathology, 1996
- Plasma concentrations of phyto-oestrogens in Japanese menThe Lancet, 1993
- Western diet and Western diseases: Some hormonal and biochemical mechanisms and associationsScandinavian Journal of Clinical and Laboratory Investigation, 1990